WGS

GeneDx Holdings Corp. NASDAQ

Healthcare ·Medical - Healthcare Information Services ·US · genedx.com

$67.93

Mkt Cap $2.0B

52w Low $55.17 11.0% of range 52w High $170.87

50d MA $71.44 200d MA $109.07

P/E (TTM) -89.6x

EV/EBITDA 534.9x

P/B 5.7x

Debt/Equity 0.5x

ROE -6.8%

P/FCF 245.2x

RSI (14) —

ATR (14) —

Beta 2.19

50d MA $71.44

200d MA $109.07

Avg Volume 742.2K

About

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete unders…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
May 4, 2026	AMC	-0.06	-0.28	-366.7%	—	—	—	—	—	—	—	—	—
Feb 23, 2026	AMC	0.11	0.14	+27.3%	87.08	-3.5%	-7.3%	-9.4%	-6.5%	-8.5%	-14.8%	-23.1%	—
Oct 28, 2025	AMC	0.28	0.49	+75.0%	137.47	-0.7%	-4.2%	-4.3%	-0.4%	+0.6%	+1.5%	+21.4%	—
Jul 29, 2025	AMC	0.10	0.50	+400.0%	91.78	+3.0%	+12.8%	+11.1%	+10.7%	+18.1%	+16.2%	+40.6%	—
Apr 30, 2025	AMC	0.11	0.28	+154.5%	66.85	+6.7%	-6.8%	+0.6%	-1.0%	-5.4%	-14.2%	+6.5%	—
Feb 18, 2025	AMC	0.04	0.70	+1650.0%	112.76	+0.2%	-1.3%	-9.9%	-15.0%	-15.8%	-15.0%	-14.2%	—
Oct 29, 2024	AMC	-0.19	0.04	+121.1%	84.02	+0.2%	-1.0%	-2.8%	-7.5%	-10.5%	-10.9%	-6.7%	—
Jul 30, 2024	AMC	-0.26	-0.11	+57.7%	30.13	+16.2%	+8.6%	+7.0%	-0.2%	-6.4%	-4.3%	+7.8%	—
Apr 29, 2024	AMC	-0.68	-0.33	+51.5%	11.00	+29.8%	+55.2%	+90.2%	+77.3%	+78.7%	+77.5%	+92.3%	—
Feb 20, 2024	AMC	-0.60	-0.59	+1.7%	5.24	-5.7%	+32.6%	+56.7%	+50.4%	+55.2%	+53.8%	+75.2%	—
Oct 30, 2023	AMC	-1.18	-0.82	+30.5%	2.67	-18.0%	-30.3%	-29.6%	-31.1%	-31.8%	-38.6%	-33.0%	—
Aug 8, 2023	AMC	-1.47	-1.65	-12.2%	6.65	-2.1%	-12.6%	-20.0%	-20.8%	-21.5%	-22.9%	-33.7%	—
May 9, 2023	AMC	-1.65	-2.82	-70.9%	8.35	-1.2%	-2.4%	-11.0%	-17.5%	-14.0%	-24.4%	-19.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 20	Canaccord Genuity	Maintains	Buy → Buy	—	$65.96	$65.96	+0.0%	+5.7%	+3.2%	+5.9%	+0.4%	+3.9%
Mar 30	Guggenheim	Maintains	Buy → Buy	—	$57.09	$57.09	+0.0%	+4.4%	+12.5%	+14.8%	+16.0%	+16.7%
Feb 24	Piper Sandler	Maintains	Overweight → Overweight	—	$87.08	$84.02	-3.5%	-7.3%	-9.4%	-6.5%	-8.5%	-14.8%
Feb 24	BTIG	Maintains	Buy → Buy	—	$87.08	$84.02	-3.5%	-7.3%	-9.4%	-6.5%	-8.5%	-14.8%
Feb 9	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$84.29	$89.54	+6.2%	+8.2%	+12.4%	+8.5%	+7.6%	+7.0%
Dec 22	Canaccord Genuity	Maintains	Buy → Buy	—	$140.44	$142.00	+1.1%	-0.2%	-3.6%	-3.1%	-4.7%	-7.9%
Dec 15	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$151.51	$151.74	+0.2%	-0.6%	-6.5%	-10.3%	-10.0%	-7.3%
Dec 12	BTIG	Maintains	Buy → Buy	—	$155.37	$157.15	+1.1%	-2.5%	-3.1%	-8.8%	-12.5%	-12.3%
Nov 4	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$138.30	$134.91	-2.5%	+0.9%	-1.0%	+0.3%	+1.0%	+3.1%
Oct 29	BTIG	Maintains	Buy → Buy	—	$137.47	$136.54	-0.7%	-4.2%	-4.3%	-0.4%	+0.6%	+1.5%
Oct 29	Canaccord Genuity	Maintains	Buy → Buy	—	$137.47	$136.54	-0.7%	-4.2%	-4.3%	-0.4%	+0.6%	+1.5%
Oct 29	Guggenheim	Maintains	Buy → Buy	—	$137.47	$136.54	-0.7%	-4.2%	-4.3%	-0.4%	+0.6%	+1.5%
Oct 22	BTIG	Maintains	Buy → Buy	—	$121.77	$122.49	+0.6%	-0.6%	+2.7%	+5.8%	+7.3%	+12.9%
Sep 11	Piper Sandler	Maintains	Overweight → Overweight	—	$123.20	$126.83	+2.9%	+2.2%	+0.6%	-0.9%	-1.5%	+3.8%
Aug 4	Piper Sandler	Maintains	Overweight → Overweight	—	$101.60	$103.03	+1.4%	+6.6%	+5.0%	+4.2%	+4.3%	+3.5%
Jul 30	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$91.78	$94.54	+3.0%	+12.8%	+11.1%	+10.7%	+18.1%	+16.2%
Jun 30	Guggenheim	Maintains	Buy → Buy	—	$91.10	$93.17	+2.3%	+1.3%	-0.9%	-1.4%	+0.6%	-5.9%
May 9	Jefferies	Upgrade	Hold → Buy	—	$56.36	$59.00	+4.7%	+4.9%	+4.7%	+8.1%	+5.5%	+12.9%
May 1	TD Securities	Maintains	Buy → Buy	—	$66.85	$71.36	+6.7%	-6.8%	+0.6%	-1.0%	-5.4%	-14.2%
May 1	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$66.85	$71.36	+6.7%	-6.8%	+0.6%	-1.0%	-5.4%	-14.2%
Feb 19	Goldman Sachs	Maintains	Neutral → Neutral	—	$112.76	$112.94	+0.2%	-1.3%	-9.9%	-15.0%	-15.8%	-15.0%
Jan 7	TD Cowen	Maintains	Buy → Buy	—	$89.61	$94.18	+5.1%	+8.3%	+7.8%	-0.3%	-5.1%	-19.6%
Oct 30	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$84.02	$84.20	+0.2%	-1.0%	-2.8%	-7.5%	-10.5%	-10.9%
Oct 30	Craig-Hallum	Maintains	Buy → Buy	—	$84.02	$84.20	+0.2%	-1.0%	-2.8%	-7.5%	-10.5%	-10.9%
Oct 30	Goldman Sachs	Maintains	Neutral → Neutral	—	$84.02	$84.20	+0.2%	-1.0%	-2.8%	-7.5%	-10.5%	-10.9%
Oct 24	Craig-Hallum	Maintains	Buy → Buy	—	$56.08	$57.18	+2.0%	+5.4%	+4.9%	-0.0%	+49.8%	+48.4%
Oct 16	Goldman Sachs	Maintains	Neutral → Neutral	—	$59.99	$60.50	+0.9%	+1.3%	-6.7%	+0.1%	-3.0%	-3.7%
Jul 31	TD Cowen	Maintains	Buy → Buy	—	$30.13	$35.00	+16.2%	+8.6%	+7.0%	-0.2%	-6.4%	-4.3%
Jul 31	Goldman Sachs	Maintains	Neutral → Neutral	—	$30.13	$35.00	+16.2%	+8.6%	+7.0%	-0.2%	-6.4%	-4.3%
Jul 31	Craig-Hallum	Maintains	Buy → Buy	—	$30.13	$35.00	+16.2%	+8.6%	+7.0%	-0.2%	-6.4%	-4.3%
Jul 31	BTIG	Maintains	Buy → Buy	—	$30.13	$35.00	+16.2%	+8.6%	+7.0%	-0.2%	-6.4%	-4.3%
Jul 17	Goldman Sachs	Maintains	Neutral → Neutral	—	$32.06	$31.31	-2.3%	+3.9%	+1.7%	-0.7%	+1.4%	+3.8%
Jun 26	BTIG	Maintains	Buy → Buy	—	$27.25	$28.25	+3.7%	-3.9%	-2.2%	-4.1%	+5.3%	+1.9%
Apr 30	TD Cowen	Maintains	Buy → Buy	—	$11.00	$14.28	+29.8%	+55.2%	+90.2%	+77.3%	+78.7%	+77.5%
Apr 30	BTIG	Maintains	Buy → Buy	—	$11.00	$14.28	+29.8%	+55.2%	+90.2%	+77.3%	+78.7%	+77.5%
Apr 22	BTIG	Maintains	Buy → Buy	—	$9.64	$9.86	+2.3%	+7.8%	+24.5%	+22.6%	+15.9%	+14.9%
Apr 15	Goldman Sachs	Maintains	Neutral → Neutral	—	$9.62	$9.78	+1.7%	+2.7%	-0.1%	-4.4%	-0.5%	+0.2%
Nov 1	Goldman Sachs	Maintains	Neutral → Neutral	—	$1.86	$1.83	-1.6%	+1.1%	-1.1%	-2.2%	-11.8%	-15.6%
Aug 9	Goldman Sachs	Maintains	Neutral → Neutral	—	$6.65	$6.51	-2.1%	-12.6%	-20.0%	-20.8%	-21.5%	-22.9%
Jul 24	Goldman Sachs	Maintains	Neutral → Neutral	—	$7.89	$7.84	-0.6%	-1.4%	-5.8%	-7.0%	-8.4%	-9.5%
Jul 21	Goldman Sachs	Maintains	Neutral → Neutral	—	$7.60	$7.63	+0.4%	+3.8%	+2.4%	-2.2%	-3.4%	-4.9%
May 15	Goldman Sachs	Maintains	Neutral → Neutral	—	$6.89	$6.83	-0.9%	+4.2%	-8.4%	-10.2%	-12.2%	-5.8%
Dec 7	Goldman Sachs	Downgrade	Buy → Neutral	—	$10.00	$10.07	+0.7%	-5.3%	+0.7%	-9.6%	-8.3%	-4.3%
Nov 15	Cowen & Co.	Maintains	Outperform → Outperform	—	$29.57	$30.36	+2.7%	-1.8%	-16.9%	-22.6%	-30.6%	-29.7%
Aug 18	BTIG	Maintains	Buy → Buy	—	$44.22	$44.88	+1.5%	-3.7%	-11.2%	-14.9%	-16.4%	-11.2%
Aug 16	Jefferies	Downgrade	Buy → Hold	—	$79.20	$58.08	-26.7%	-33.3%	-44.2%	-46.2%	-50.4%	-52.5%

Recent Filings

8-K · 1.01 ! Medium

GeneDx Holdings Corp. -- 8-K 1.01: Financing / Debt Agreement

GeneDx Holdings (WGS) secured a $100 million loan agreement, providing capital to support operations and potentially fund growth initiatives or reduce existing debt obligations.

Mar 2

8-K

GeneDx Holdings Corp. -- 8-K Filing

GeneDx reported 2025 fourth-quarter and full-year financial results, showing the rare disease diagnostics company's performance through its genomic sequencing business.

Feb 23

Data updated apr 27, 2026 9:15am · Source: massive.com